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Abstract
Background: Genomic copy number alterations are widely associated with a broad range of human tumors and offer 
the potential to be used as a diagnostic tool. Especially in the emerging era of personalized medicine medical 
informatics tools that allow the fast visualization and analysis of genomic alterations of a patient's genomic profile for 
diagnostic and potential treatment purposes increasingly gain importance.
Results: We developed CNAReporter, a software tool that allows users to visualize SNP-specific data obtained from 
Affymetrix arrays and generate PDF-reports as output. We combined standard algorithms for the analysis of 
chromosomal alterations, utilizing the widely applied GenePattern framework. As an example, we show genome 
analyses of two patients with distinctly different CNA profiles using the tool.
Conclusions: Glioma subtypes, characterized by different genomic alterations, are often treated differently but can be 
difficult to differentiate pathologically. CNAReporter offers a user-friendly way to visualize and analyse genomic 
changes of any given tumor genomic profile, thereby leading to an accurate diagnosis and patient-specific treatment.
Background
Genomic copy number alterations are widely associated
with a broad range of human diseases [1]. In general,
tumors [2] have genomic abnormalities that are largely
characterized by copy number alterations. Specifically,
amplifications, deletions and allelic imbalances are hall-
marks of human gliomas [3,4]. Such genomic data offer
important biological insights into the pathogenesis of the
disease and might serve as valuable clinical and diagnos-
tic tool. By classifying patients into more homogeneous
tumor groups, genomic alteration data also might allow
the enrichment of patient subpopulations with genetic
targets that are more likely to respond to specific molecu-
larly targeted therapy.
Copy number analysis for a single patient usually
include several major steps, such as (1) raw data process-
ing with normalization and calculation of log2 ratios of
probe intensities in tumor compared to either a reference
sample or reference set - the values representing copy
numbers; (2) smoothing and segmentation of copy num-
bers followed by selection of areas of copy number altera-
tions (CNA); (3) if available, analysis of loss-of-
heterozygosity (LOH) and (4) visualization of the CNA/
LOH profile.
Many tools for the analysis of copy number profiles
have been developed by the scientific community and are
often freely available and cover all steps of analyses such
as Affymetrix CNAT [5], CNAG [6], dChipSNP [7],
ArrayFusion [8], perl-based PennCNV [9], as well as sev-
eral R/Bioconductor packages like aroma.affymetrix [10]
and SNPchip [11]. Most of these software packages, how-
ever, require that the user has substantial bioinformatics
knowledge and computer/programming skills. The out-
put is generally an interactive browser of genomic profiles
and/or exported figures/text files. With an ever-increas-
ing demand for patient-specific genomic data by clinical
researchers and clinicians, however, there is a great need
for analyses tools and output formats that individuals
without computational expertise can utilize to generate
such information.
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Our goal, therefore, was to create an easy to use tool for
non-sophisticated users who would want a "snapshot" of
the genomic profile for a particular tumor/tissue sample
from the raw microarray data and to obtain that data in
an easy to understand printable format suitable for clini-
cal trial study charts or medical records. Based on the
widely used GenePattern framework [12], we developed
CNAReporter, a reporting tool that interprets experi-
mental measurements from high resolution Human Map-
ping GeneChip arrays (Affymetrix Inc., Santa Clara, CA)
[13]. Providing statistical treatment of such data,
CNAReporter determines and annotates regions of
genomic alterations in a sample and summarizes results
in a printable PDF-file. Specifically, we show the useful-
ness of CNAReporter as a clinical tool that supports the
accurate diagnosis and treatment of patients with pri-
mary brain tumors.
Implementation
Data, Workflow and User Interface
CNAReporter calls for a matched pair of patient-specific
tumor and germline reference CEL and CHP files (Figure
1), which are usually generated by Affymetrix GTYPE or
Genotyping Console software [14,15].
We designed CNAReporter as a GenePattern 3.0 pipe-
line [12], consisting of two modules (Figure 1). From
paired input data, the module GenerateAffyCNTfiles cal-
culates copy numbers (CN), provides smoothed CN-pro-
files and calculates LOH status of genomic locations. All
results are stored in standard Affymetrix CNT files. The
module was written in Perl as a wrapper for platform cor-
responding binary executables of the Affymetrix DevNet
Tools copy-number pipeline [16], allowing the on-the-fly
generation of all intermediate files. Details about the cor-
responding algorithms can be found in [5].
Reading generated CNT-files, the module Gener-
ateAlterationReport  determines CNA and LOH areas.
The final output is a printable PDF-file that provides a
table of altered genomic areas and graphic visualizations
as a genomic profile and chromosome plot (Figure 1).
The module was implemented in MATLAB (The Math-
works, Inc., Natick, MA) requiring the Bioinformatics
Toolbox to create chromosome plots and using a Perl
script to generate the final PDF report.
CNAReporter provides a user interface to a standard
GenePattern pipeline, allowing the input of the afore-
mentioned Affymetrix-specific files. Advanced options
include the selection of thresholds for the detection of
CNA and LOH as well as the ability to plot genomic pro-
files for individual chromosomes.
CNAReporter runs on all platforms that GenePattern,
MATLAB and Affymetrix tools support, including Win-
dows, Mac, Linux and Sun Solaris. Currently supported
arrays include Affymetrix 500K, 100K and 10K human
mapping arrays. Since the latest SNP5 and SNP6 arrays
require different algorithms to estimate copy numbers,
their support will be added in the future.
Determination of copy numbers
Copy numbers are calculated using Affymetrix Copy
Number Analysis Tool (CNAT 4), a set of command line
programs. We allow filtering out SNPs with large PCR
f r a g m e n t  l e n g t h  ( M a x F r a g S i z e  p a r a m e t e r ,  6 0 0  b p  b y
default) to support samples with partially degraded DNA
[17]. For standard fresh-frozen samples this parameter
can be set to 0 to include all SNPs. After probe-level nor-
malization and summarization, calculated log2-tran-
formed ratios are used to estimate raw copy numbers
(CN). Using a Gaussian approach, raw SNP profiles are
smoothed (>500 kb window by default) and segmented by
a Hidden Markov Model approach [18,19]. Raw and
smoothed copy numbers are saved in an Affymetrix-
based CNT file.
Figure 1 Workflow of CNAReporter, describing sample input 
files, functions of CNAReporter modules and output examples. 
Specifically, areas of significant genomic change are tabulated in a 
PDF-file, characterized by its corresponding type, such as chromosom-
al gain, loss and allelic imbalances and linked to UCSC Genome Brows-
er [20]. Furthermore, the patient specific report includes a genomic 
profile that provides raw and smoothed profiles of log2 ratios of sam-
ple to reference intensities representing copy numbers, areas of loss-
of-heterozygosity (LOH) and genomic calls. These areas are finally la-
belled in a plot of chromosomal changes that are optionally available 
for each chromosome separately.Kotliarov et al. BMC Medical Genomics 2010, 3:11
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Determination of loss of heterozygosity (LOH)
LOH calls for each SNP are determined by comparing
corresponding genomic calls in the tumor and the ger-
mline sample, provided that SNPs are heterozygous in the
reference sample. Specifically, we use the LOH algorithm
as implemented in CNAT 4 [5]. LOH values are also seg-
mented utilizing a Hidden Markov Model and saved in an
Affymetrix-based CNT file.
CNA areas
Utilizing copy numbers and LOHs that characterize the
underlying tumor sample by individual SNPs, CNARe-
porter applies three threshold parameters to define areas
of CNAs. Increasing the absolute values of those parame-
ters makes detection more conservative, thereby,
decreasing the number of false positive areas but increas-
ing the possibility of missing real changes. In addition,
neighboring LOH areas are combined if they are within a
certain threshold distance from each other (set by
LOHMergeThreshold parameter, 2 Mbp by default). Low-
ering this parameter may cause splitting of LOH areas
due to errors in genotyping calls. Default thresholds are
determined empirically from the analysis of other brain
tumor samples.
Results
Patient examples
Tissue from fresh frozen tumor specimens and resultant
data were collected under an NCI-IRB (FWA #
00005897/IRB# 00000001)-approved protocol
(NCI#:02C0140). Informed consent was obtained from
each patient and documented in the medical records.
Specimens and data were de-identified to comply with
patients' privacy rules.
Routinely, we analyse genomic profiles of glioma
patients with CNAReporter. Specifically, we extract and
hybridize DNA from patient tumor samples to the
Affymetrix 500K SNP chips [13] using methods previ-
ously reported [17]. As representative examples, that
demonstrate the usefulness of CNAReporter for diagnos-
tic and treatment purposes, we show genome analyses of
two patients with distinctly different CNA profiles. Given
their general resistance to conventional therapy glioblas-
tomas are the most common and malignant type of
gliomas and are treated aggressively with a potentially
toxic combination of high-dose cranial radiotherapy and
chemotherapy. A much less common type of malignant
glioma, called an anaplastic/malignant oligodendro-
glioma, can occasionally be very difficult to distinguish
from a glioblastoma by standard pathological criteria.
Clinically the distinction between these two types of
gliomas, however, is utterly important since oligodendro-
gliomas, harbouring the characteristic chromosome 1p
and 19q deletion, are often significantly more sensitive to
treatment than glioblastomas. Thus, patients with oligo-
dendrogliomas can often be treated with drug therapy
alone thereby sparing them the potential long-term
neuro-cognitive toxicity from brain radiation. In Figure
2A, we observe clear deletions of chromosomes 1p and
19q, an area that is typical for patients with an oligoden-
droglioma. This is in clear contrast to the genomic profile
of the tumor seen in Figure 2B where the 1p/19q deletion
is absent whereas a strong amplification of chromosome
7 (with a high peak corresponding to the epidermal
growth factor receptor), deletion of chromosome 10 and
homozygous deletion on chromosome 9 are seen; all
highly characteristic of a glioblastoma. Thus, through
ready access to CNAReporter, a clinician would be able to
offer the appropriate treatment to both patients, some-
thing that may not have occurred if treatment were based
purely on standard histopathological criteria, as is cur-
rently the standard of care.
Conclusions
We introduced CNAReporter, a user-friendly, integrated
tool that allows the quick analysis and visualization of
chromosomal alterations. In particular, CNAReporter
provides detailed high-quality reports of genomic altera-
tions in a printable format, allowing our application to be
used as a standard tool for clinical diagnostics and deci-
sion-making. Specifically, we use CNAReporter routinely
for the analysis of genomic alterations of brain tumor tis-
sues, potentially allowing us to make objective tumor
subtype diagnoses, stratify patients into biologically more
homogeneous tumor subgroups for clinical trials and
select patient-specific treatments based on objective
genomic data. We designed CNAReporter as a pipeline in
GenePattern environment, a well-known open-source
web-based framework that supports multiple platforms.
Once properly installed on a server, GenePattern does
not require additional software to be installed on the
user's computer and can be accessed from any site with
only a web browser. The GenePattern framework pro-
vides security, job management, uniform interface, rela-
tive ease of customization and integration with other
developers' tools. Currently, GenePattern already has sev-
eral modules for SNP analysis in its repository, such as
the preprocessing SNPFileCreator module (which does
not implement paired analysis) and GISTIC for chromo-
somal aberrations discovery in multi-sample datasets [4].
We believe our tool would be a significant addition to this
suite. Due to its open architecture, CNAReporter can
easily be further developed in an open-source sense and
integrated into other systems for genomic analysis.Kotliarov et al. BMC Medical Genomics 2010, 3:11
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Figure 2 Diagnostic examples. In (A) we show a patient sample predominantly with strong deletions on chromosome 1, 4 and 19. The prevalence 
of a deletion and loss-of-heterozygosity (LOH) of 1p and 19q areas indicates the presence of an oligodendroglioma (red shaded areas in the genomic 
profile and chromosome plot). In (B), a patient sample shows a variety of copy number alterations. While the 1p/19q deletions are missing, we find a 
large deletion with LOH on chromosome 10, homozygous deletion on chromosome 9 (red shaded areas) and amplification of chromosome 7 (blue 
shaded areas), changes that are prototypic for a glioblastoma.Kotliarov et al. BMC Medical Genomics 2010, 3:11
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Availability and Requirements
CNAReporter with installation and usage instructions as
well as all required files can be downloaded from http://
gforge.nci.nih.gov/projects/cnareport.
The program is available for Linux/Unix, Mac and
Windows operating systems, and requires MATLAB
2007b (or later) with Bioinformatics Toolbox, Perl 5
(including CRAN libraries) and GenePattern 3.0 (or
later).
Abbreviations
CN: (DNA) copy number; CNA: copy number alteration; LOH: loss of heterozy-
gosity; SNP: single nucleotide polymorphism; (M)bp: (Mega) base pairs.
Authors' contributions
YK, JCZ, SW and HF formulated the requirements of the tool. YK designed the
pipeline. YK, SB and HC implemented the tool. HF coordinated the study. All
authors read and approved the final manuscript.
Acknowledgements
This research was supported by the Intramural Research Program of the NIH, 
National Cancer Institute.
Author Details
1Neuro-Oncology Branch, National Cancer Institute, National Institutes of 
Neurological Disorder and Stroke, National Institutes of Health, 37 Convent 
Drive, Bethesda, MD 20892, USA and 2NCI Center for Biomedical Informatics 
and Information Technology, National Cancer Institute, National Institutes of 
Health, 2115 E Jefferson St., Rockville, MD 20852, USA
References
1. Weber BL: Cancer genomics.  Cancer Cell 2002, 1(1):37-47.
2. Albertson DG, Collins C, McCormick F, Gray JW: Chromosome 
aberrations in solid tumors.  Nat Genet 2003, 34(4):369-376.
3. Kotliarov Y, Steed ME, Christopher N, Walling J, Su Q, Center A, Heiss J, 
Rosenblum M, Mikkelsen T, Zenklusen JC, et al.: High-resolution global 
genomic survey of 178 gliomas reveals novel regions of copy number 
alteration and allelic imbalances.  Cancer Res 2006, 66(19):9428-9436.
4. Beroukhim R, Getz G, Nghiemphu L, Barretina J, Hsueh T, Linhart D, 
Vivanco I, Lee JC, Huang JH, Alexander S, et al.: Assessing the significance 
of chromosomal aberrations in cancer: methodology and application 
to glioma.  Proc Natl Acad Sci USA 2007, 104(50):20007-20012.
5. CNAT 4.0: Copy Number and Loss of Heterozygosity Estimation 
Algorithms for the GeneChip(r) Human Mapping 10/50/100/250/500K 
Array Set   [http://www.affymetrix.com/support/technical/whitepapers/
cnat_4_algorithm_whitepaper.pdf]
6. Nannya Y, Sanada M, Nakazaki K, Hosoya N, Wang L, Hangaishi A, 
Kurokawa M, Chiba S, Bailey DK, Kennedy GC, et al.: A robust algorithm for 
copy number detection using high-density oligonucleotide single 
nucleotide polymorphism genotyping arrays.  Cancer Res 2005, 
65(14):6071-6079.
7. Lin M, Wei LJ, Sellers WR, Lieberfarb M, Wong WH, Li C: dChipSNP: 
significance curve and clustering of SNP-array-based loss-of-
heterozygosity data.  Bioinformatics 2004, 20(8):1233-1240.
8. Yang TP, Chang TY, Lin CH, Hsu MT, Wang HW: ArrayFusion: a web 
application for multi-dimensional analysis of CGH, SNP and microarray 
data.  Bioinformatics 2006, 22(21):2697-2698.
9. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, Hakonarson H, Bucan 
M: PennCNV: an integrated hidden Markov model designed for high-
resolution copy number variation detection in whole-genome SNP 
genotyping data.  Genome Res 2007, 17(11):1665-1674.
10. Bengtsson H, Irizarry R, Carvalho B, Speed TP: Estimation and assessment 
of raw copy numbers at the single locus level.  Bioinformatics 2008, 
24(6):759-767.
11. Scharpf RB, Ting JC, Pevsner J, Ruczinski I: SNPchip: R classes and 
methods for SNP array data.  Bioinformatics 2007, 23(5):627-628.
12. Reich M, Liefeld T, Gould J, Lerner J, Tamayo P, Mesirov JP: GenePattern 
2.0.  Nat Genet 2006, 38(5):500-501.
13. Komura D, Shen F, Ishikawa S, Fitch KR, Chen W, Zhang J, Liu G, Ihara S, 
Nakamura H, Hurles ME, et al.: Genome-wide detection of human copy 
number variations using high-density DNA oligonucleotide arrays.  
Genome Res 2006, 16(12):1575-1584.
14. Di X, Matsuzaki H, Webster TA, Hubbell E, Liu G, Dong S, Bartell D, Huang J, 
Chiles R, Yang G, et al.: Dynamic model based algorithms for screening 
and genotyping over 100 K SNPs on oligonucleotide microarrays.  
Bioinformatics 2005, 21(9):1958-1963.
15. BRLMM: an Improved Genotype Calling Method for the GeneChip® 
Human Mapping 500K Array Set   [http://www.affymetrix.com/support/
technical/whitepapers/brlmm_whitepaper.pdf]
16. Affymetrix DevNet Tools   [http://www.affymetrix.com/
partners_programs/programs/developer/tools/devnettools.affx]
17. Jacobs S, Thompson ER, Nannya Y, Yamamoto G, Pillai R, Ogawa S, Bailey 
DK, Campbell IG: Genome-wide, high-resolution detection of copy 
number, loss of heterozygosity, and genotypes from formalin-fixed, 
paraffin-embedded tumor tissue using microarrays.  Cancer Res 2007, 
67(6):2544-2551.
18. Fridlyand J, Snijders AM, Pinkel D, Albertson DG, Jain AN: Hidden Markov 
models approach to the analysis of array CGH data.  Jourrnal of 
Multivariate Analysis 2004, 90:132-153.
19. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, 
Gautier L, Ge Y, Gentry J, et al.: Bioconductor: open software 
development for computational biology and bioinformatics.  Genome 
Biol 2004, 5(10):R80.
20. UCSC Genome Browser   [http://genome.ucsc.edu]
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1755-8794/3/11/prepub
doi: 10.1186/1755-8794-3-11
Cite this article as: Kotliarov et al., CNAReporter: a GenePattern pipeline for 
the generation of clinical reports of genomic alterations BMC Medical Genom-
ics 2010, 3:11
Received: 12 August 2009 Accepted: 9 April 2010 
Published: 9 April 2010
This article is available from: http://www.biomedcentral.com/1755-8794/3/11 © 2010 Kotliarov et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Medical Genomics 2010, 3:11